Yantai Dongcheng Pharmaceutical GroupLtd Balance Sheet Health
Financial Health criteria checks 6/6
Yantai Dongcheng Pharmaceutical GroupLtd has a total shareholder equity of CN¥5.5B and total debt of CN¥839.7M, which brings its debt-to-equity ratio to 15.4%. Its total assets and total liabilities are CN¥8.6B and CN¥3.2B respectively. Yantai Dongcheng Pharmaceutical GroupLtd's EBIT is CN¥233.6M making its interest coverage ratio 3.2. It has cash and short-term investments of CN¥955.2M.
Key information
15.4%
Debt to equity ratio
CN¥839.75m
Debt
| Interest coverage ratio | 3.2x |
| Cash | CN¥955.20m |
| Equity | CN¥5.47b |
| Total liabilities | CN¥3.17b |
| Total assets | CN¥8.64b |
Recent financial health updates
Yantai Dongcheng Pharmaceutical GroupLtd (SZSE:002675) Has A Pretty Healthy Balance Sheet
Aug 23
Is Yantai Dongcheng Pharmaceutical GroupLtd (SZSE:002675) A Risky Investment?
Mar 15Recent updates
Yantai Dongcheng Pharmaceutical GroupLtd (SZSE:002675) Has A Pretty Healthy Balance Sheet
Aug 23Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s (SZSE:002675) Business Is Yet to Catch Up With Its Share Price
Jul 12News Flash: 7 Analysts Think Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SZSE:002675) Earnings Are Under Threat
May 06Yantai Dongcheng Pharmaceutical GroupLtd's (SZSE:002675) Problems Go Beyond Weak Profit
May 05Is Yantai Dongcheng Pharmaceutical GroupLtd (SZSE:002675) A Risky Investment?
Mar 15Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s (SZSE:002675) P/E Is On The Mark
Feb 27Financial Position Analysis
Short Term Liabilities: 002675's short term assets (CN¥2.6B) exceed its short term liabilities (CN¥1.7B).
Long Term Liabilities: 002675's short term assets (CN¥2.6B) exceed its long term liabilities (CN¥1.5B).
Debt to Equity History and Analysis
Debt Level: 002675 has more cash than its total debt.
Reducing Debt: 002675's debt to equity ratio has reduced from 17.8% to 15.4% over the past 5 years.
Debt Coverage: 002675's debt is well covered by operating cash flow (43.1%).
Interest Coverage: 002675's interest payments on its debt are well covered by EBIT (3.2x coverage).